AllianceBernstein’s Ambrx Biopharma Inc AMAM Stock Holding History

AllianceBernstein’s Portfolio AMAM Stock Details AMAM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-258,364	Closed	-$3.68M	–	3202
2023 Q4	$3.68M	Buy	258,364 +211,068	+446%	+$2.4M	﹤0.01%	1635
2023 Q3	$544K	Buy	+47,296	New	+$644K	﹤0.01%	2533
2021 Q3	–	Sell	-70,000	Closed	-$1.37M	–	3360
2021 Q2	$1.37M	Buy	+70,000	New	+$1.19M	﹤0.01%	2390

AllianceBernstein's AMAM Position: Q1 2024 in Review

AllianceBernstein sold out of Ambrx Biopharma Inc (AMAM) in Q1 2024, closing a stake of 258,364 shares — an estimated $3.68M sold.

AllianceBernstein first reported a position in AMAM in Q2 2021 and held it in 3 quarters. The position peaked at $3.68M in Q4 2023. 0 funds tracked by Wall St. Rank hold AMAM as of Q1 2024.

AllianceBernstein reported no remaining Ambrx Biopharma Inc position as of Q1 2024 after selling out during the quarter.
AllianceBernstein sold 258,364 Ambrx Biopharma Inc shares in Q1 2024, an estimated $3.68M.
AllianceBernstein first reported a position in Ambrx Biopharma Inc in Q2 2021 and held it in 3 quarters.
AllianceBernstein's Ambrx Biopharma Inc position peaked at $3.68M in Q4 2023.
0 funds tracked by Wall St. Rank held Ambrx Biopharma Inc as of Q1 2024.

Based on AllianceBernstein's 13F filing for Q1 2024, filed 14 May 2024.